Rapid remission of a large pleomorphic rhabdomyosarcoma with radiation and a novel schedule of simultaneous high-dose cisplatinUPHOUSE, W. J; LEE, Y.-T. M; RONQUILLO, A. P et al.Cancer drug delivery. 1989, Vol 5, Num 4, pp 205-206, issn 0732-9482Article

Doxorubicin-loaded nanoparticles: increased efficiency in murine hepatic metastasesCHIANNILKULCHAI, N; DRIOUICH, Z; BENOIT, J. P et al.Cancer drug delivery. 1989, Vol 5, Num 1, pp 1-11, issn 0732-9482Article

Pharmacokinetics of methotrexate and 7-hydroxy-methotrexate after methotrexate infusionsBORE, P; ILIADIS, A; CATALIN, J et al.Cancer drug delivery. 1987, Vol 4, Num 3, pp 177-183, issn 0732-9482Article

Ultrastructural and freeze fracture localization of multilamellar liposomes containing a lipophilic cisplatin analogue in normal tissues and liver metastases of M5076 reticulosarcomaPEREZ-SOLER, R; KHOKHAR, A. R; LAUTERSZTAIN, J et al.Cancer drug delivery. 1987, Vol 4, Num 2, pp 75-88, issn 0732-9482Article

Comparative distribution of free doxorubicin and poly-L-aspartic acid linked doxorubicin in MS-2 sarcoma bearing miceMAZZONI, A; GAMBETTA, R. A; TRAVE, F et al.Cancer drug delivery. 1986, Vol 3, Num 3, pp 163-172, issn 0732-9482Article

Studies on tumor necrosis factor (TNF). III: Plasma disappearance curves after intramuscular, subcutaneous, intraperitoneal, and oral administration of human recombinant TNFPACINI, A; MAIOLI, E; BOCCI, V et al.Cancer drug delivery. 1987, Vol 4, Num 1, pp 17-23, issn 0732-9482Article

Effect of cyclophosphamide on the immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in ratsHARKONEN, S; MISCHAK, R; LOPEZ, H et al.Cancer drug delivery. 1987, Vol 4, Num 3, pp 151-157, issn 0732-9482Article

Investigation of the role of mononuclear phagocytes in the transporation of doxorubicin-containing liposomes into a solid tumorSTORM, G; VAN GESSEL, H. J. G. M; STEERENBERG, P. A et al.Cancer drug delivery. 1987, Vol 4, Num 2, pp 89-104, issn 0732-9482Article

Schedule-dependent toxicity of tumor necrosis factor in rodentsLIDDIL, J. D; DORR, R. T.Cancer drug delivery. 1987, Vol 4, Num 3, pp 159-167, issn 0732-9482Article

The pharmacology of hepatic regional administration of cisplatin in a rabbit modelKAR, R; OPFELL, R. W; WILE, A. G et al.Cancer drug delivery. 1987, Vol 4, Num 4, pp 225-232, issn 0732-9482Article

1-β-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugsCHUNG IL HONG; KIRISITS, A. J; BUCHHEIT, D. J et al.Cancer drug delivery. 1986, Vol 3, Num 2, pp 101-113, issn 0732-9482Article

Cytotoxicity of 2-chlorodeoxyadenosine in a human tumor colony-forming assayHUTTON, J. J; VON HOFF, D. D.Cancer drug delivery. 1986, Vol 3, Num 2, pp 115-122, issn 0732-9482Article

The preparation of large volumes of homogeneous, sterile liposomes containing various lipophilic cytostatic drugs by the use of a capillary dialyzerSCHWENDENER, R. A.Cancer drug delivery. 1986, Vol 3, Num 2, pp 123-129, issn 0732-9482Article

The effect of amitriptyline on the central nervous system penetration of methotrexateHEIDEMAN, R. L; BALIS, F. M; ZIMM, S et al.Cancer drug delivery. 1986, Vol 3, Num 4, pp 219-222, issn 0732-9482Article

A comparison of in vitro toxicity and antifungal efficacy of membrane-active drugs after liposome encapsulationMEHTA, R. T; HOPFER, R. L; JULIANO, R. L et al.Cancer drug delivery. 1989, Vol 5, Num 3, pp 113-117, issn 0732-9482Article

A new in vitro screening system for anticancer drugs for the treatment of non-small cell lung cancerHANAUSKE, U; HANAUSKE, A.-R; CLARK, G. M et al.Cancer drug delivery. 1989, Vol 5, Num 3, pp 97-111, issn 0732-9482Article

A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspectsMAGID, D. M; VOKES, E. E; SCHILSKY, R. L et al.Cancer drug delivery. 1989, Vol 5, Num 3, pp 137-145, issn 0732-9482Article

Endocytic and tumoricidal heterogeneity of rat liver macrophage populationsDAEMEN, T; VENINGA, A; ROERDINK, F. H et al.Cancer drug delivery. 1989, Vol 5, Num 4, pp 157-167, issn 0732-9482Article

5-Fluorouracil incorporation into RNA of a rat liver adenocarcinoma after hepatic artery injection together with degradable starch microspheresTEDER, H; ERICHSEN, C; CHRISTENSSON, P. I et al.Cancer drug delivery. 1987, Vol 4, Num 3, pp 169-176, issn 0732-9482Article

Continuous infusion or intravenous bolus: what is the rationale for doxorubicin administration?ROBERT, J.Cancer drug delivery. 1987, Vol 4, Num 3, pp 191-199, issn 0732-9482Article

In vitro chemosensitivity testing using the multicellular tumor spheroid modelKERR, D. J; WHELDON, T. E; KERR, A. M et al.Cancer drug delivery. 1987, Vol 4, Num 2, pp 63-73, issn 0732-9482Article

Comparison of mixantrone and ametantrone in human acute myelocytic leukemia cells in culture and in bone marrow granulocyte-macrophage progenitor cellsFOUNTZILAS, G; OHNUMA, T; RAMMOS, K et al.Cancer drug delivery. 1986, Vol 3, Num 2, pp 93-100, issn 0732-9482Article

Controlled studies of a new microprocessor-based portable infusion pumpDORR, R. T; SALMON, S. E; MARSH, M. E et al.Cancer drug delivery. 1986, Vol 3, Num 2, pp 139-146, issn 0732-9482Article

Phase II trial of intracarotid BCNU and cisplatin in primary malignant brain tumorsFEUN, L. G; YA-YEN LEE; YUNG, W. K. A et al.Cancer drug delivery. 1986, Vol 3, Num 2, pp 147-156, issn 0732-9482Article

Potentiation of hydroxyurea cytotoxicity by iron-chelating agent in murine tumor models in vitroSATYAMOORTHY, K; CHITNIS, M. P; PRADHAN, S. G et al.Cancer drug delivery. 1986, Vol 3, Num 3, pp 173-182, issn 0732-9482Article